Home / Departments / Clinical Sciences / John W. Deming Department of Medicine / Hematology & Medical Oncology
Founded over 50 years ago, the Section has a rich history as an active training program for generations of hematologists/oncologists. Through close affiliation with 3 hospitals including the Tulane University Hospital and Clinic, the Southeast Veterans Louisiana Health Care System and the Medical Center of Louisiana at New Orleans, Tulane hematologists/oncologists and trainees see patients referred from throughout the southeast with a wide array of disorders. Section faculty members possess notable expertise in hematology, oncology and bone marrow transplantation.
Section programs in benign hematology include the Louisiana Center for Bleeding and Clotting Disorders, the only federally funded center in the state providing expert care, and cutting edge research for patients suffering from hemophilia and other coagulation disorders. In addition, the Adult Sickle Cell Day Hospital is an innovative, state of the art program that represents the only one of its kind in Louisiana and is pioneering effective management strategies, as well as clinical research studies for patients with sickle disorders.Read More
The Section's oncology programs are closely linked with the Tulane Cancer Center, which is dedicated to a comprehensive, disease specific, team approach to the care of cancer patients. Comprehensive clinics, many with associated multi-disciplinary tumor conferences, are held for patients with breast cancer, otolaryngologic malignancies, gastrointestinal and liver cancers, genitourinary cancer, and hematologic malignancies. Of particular note are the recently developed programs in liver cancer and prostate cancer, both of which are led by internationally known faculty and attract patients from around the country.
The Tulane Bone Marrow Transplant Program is active in both autologous and allogeneic transplantation and is approved for unrelated stem cell transplantation. Currently, it is the only program in the state that performs allogeneic stem cell transplantation for adults. The program draws referrals from several states, and is active in both clinical and translational research trials.
With a growing base of both clinical and research faculty, the Section enjoys an excellent regional and national reputation as a center of specialized, comprehensive patient care as well as an emerging leader in research in many areas. While some faculty members engage in basic scientific research, all are deeply involved in translational research, in a concerted effort to deliver expert care from bench to bedside.